ALX ONCOLOGY HOLDINGS INC Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALX ONCOLOGY HOLDINGS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALX ONCOLOGY HOLDINGS INC for July 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 38,660 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 664,660 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 18,705 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 137,286 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 11,110 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 150,801 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 8,175 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 59,998 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 39,758 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 683,523 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 222,752 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,633,743 | 0 | 0 | |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | C | 0.00 | 111,528 | 0 | 120,212 | 8.7 K to 120.2 K (+1,284.29 %) |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | P | 19.00 | 22,000 | 418,000 | 22,000 | 0 to 22 K |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | C | 0.00 | 1,498,984 | 0 | 2,023,469 | 524.5 K to 2 M (+285.80 %) |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | P | 19.00 | 378,000 | 7,182,000 | 378,000 | 0 to 378 K |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | C | 0.00 | 249,632 | 0 | 309,222 | 59.6 K to 309.2 K (+418.92 %) |
| Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | C | 0.00 | 1,831,027 | 0 | 2,268,087 | 437.1 K to 2.3 M (+418.94 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Vivo Capital IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,158,851 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Vivo Capital IX, LLC | 10% Owner | Buy | P | 19.00 | 185,526 | 3,524,994 | 185,526 | 0 to 185.5 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Vivo Capital IX, LLC | 10% Owner | Buy | C | 0.00 | 3,245,048 | 0 | 4,034,522 | 789.5 K to 4 M (+411.04 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Vivo Capital IX, LLC | 10% Owner | Buy | P | 19.00 | 789,474 | 15,000,006 | 789,474 | 0 to 789.5 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Option Exercise | C | 0.00 | 2,105,901 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Buy | P | 19.00 | 975,000 | 18,525,000 | 975,000 | 0 to 975 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Buy | C | 0.00 | 2,105,901 | 0 | 2,161,981 | 56.1 K to 2.2 M (+3,755.17 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Hemrajani Rekha | Director | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 52,647 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 15,794 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 78,175 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 1,052,950 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 490,411 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 2,398,588 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 3,100,020 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | C | 0.00 | 52,647 | 0 | 54,083 | 1.4 K to 54.1 K (+3,666.23 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | C | 0.00 | 93,969 | 0 | 113,287 | 19.3 K to 113.3 K (+486.43 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | C | 0.00 | 3,941,949 | 0 | 5,268,325 | 1.3 M to 5.3 M (+297.20 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | P | 19.00 | 850,000 | 16,150,000 | 850,000 | 0 to 850 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | C | 0.00 | 3,100,020 | 0 | 3,969,789 | 869.8 K to 4 M (+356.42 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pietzke Steffen | VP Fin & Chief Acct ... | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GARCIA PETER S | Chief Financial Off ... | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Caffo Nathan | Chief Business Offi ... | Option Exercise | C | 0.00 | 10,529 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Caffo Nathan | Chief Business Offi ... | Buy | C | 0.00 | 10,529 | 0 | 11,254 | 725 to 11.3 K (+1,452.28 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Option Exercise | C | 0.00 | 5,264 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Option Exercise | C | 0.00 | 1,803 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Option Exercise | C | 0.00 | 20,225 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Buy | C | 0.00 | 27,292 | 0 | 541,346 | 514.1 K to 541.3 K (+5.31 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 38,660 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 664,660 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 18,705 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 137,286 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 10,529 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 11,110 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 150,801 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 8,175 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 59,998 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 39,758 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 683,523 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 222,752 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 1,633,743 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 78,175 | 0 | 0 | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 111,528 | 0 | 120,212 | 8.7 K to 120.2 K (+1,284.29 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | P | 19.00 | 22,000 | 418,000 | 22,000 | 0 to 22 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 1,498,984 | 0 | 2,023,469 | 524.5 K to 2 M (+285.80 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | P | 19.00 | 378,000 | 7,182,000 | 378,000 | 0 to 378 K |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 249,632 | 0 | 309,222 | 59.6 K to 309.2 K (+418.92 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 1,831,027 | 0 | 2,268,087 | 437.1 K to 2.3 M (+418.94 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 88,704 | 0 | 107,220 | 18.5 K to 107.2 K (+479.07 %) |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 1,052,950 | 0 | 0 | ||
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 490,411 | 0 | 0 | ||
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 2,398,588 | 0 | 0 | ||
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 3,100,020 | 0 | 0 | ||
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 78,175 | 0 | 0 | ||
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | P | 19.00 | 3,000 | 57,000 | 99,406 | 96.4 K to 99.4 K (+3.11 %) | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | P | 19.00 | 850,000 | 16,150,000 | 5,268,325 | 4.4 M to 5.3 M (+19.24 %) | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | C | 0.00 | 3,941,949 | 0 | 4,418,325 | 476.4 K to 4.4 M (+827.49 %) | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | C | 0.00 | 3,100,020 | 0 | 3,969,789 | 869.8 K to 4 M (+356.42 %) | |
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | C | 0.00 | 78,175 | 0 | 96,406 | 18.2 K to 96.4 K (+428.80 %) | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Option Exercise | A | 19.00 | 24,009 | 456,171 | 24,009 | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Nielsen Jack | Director | Option Exercise | A | 19.00 | 24,009 | 456,171 | 24,009 | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | A | 19.00 | 24,009 | 456,171 | 24,009 | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | A | 19.00 | 24,009 | 456,171 | 24,009 | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Option Exercise | A | 19.00 | 89,657 | 1,703,483 | 89,657 | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 19.00 | 41,789 | 793,991 | 41,789 | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 19.00 | 88,137 | 1,674,603 | 88,137 | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Caffo Nathan | Chief Business Offi ... | Option Exercise | A | 19.00 | 22,794 | 433,086 | 22,794 | |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President &CEO | Option Exercise | A | 19.00 | 272,771 | 5,182,649 | 272,771 |